LFWD Stock Overview
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ReWalk Robotics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.48 |
| 52 Week High | US$9.10 |
| 52 Week Low | US$3.90 |
| Beta | 2.13 |
| 1 Month Change | -11.46% |
| 3 Month Change | 2.28% |
| 1 Year Change | 5.84% |
| 3 Year Change | -61.90% |
| 5 Year Change | -85.08% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Is ReWalk Robotics (NASDAQ:LFWD) In A Good Position To Deliver On Growth Plans?
May 30
Investors Give ReWalk Robotics Ltd. (NASDAQ:LFWD) Shares A 28% Hiding
Mar 14We Think ReWalk Robotics (NASDAQ:RWLK) Needs To Drive Business Growth Carefully
Jan 09Shareholders May Be A Bit More Conservative With ReWalk Robotics Ltd.'s (NASDAQ:RWLK) CEO Compensation For Now
Sep 06Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Deliver On Growth Plans?
Jul 04Is ReWalk Robotics (NASDAQ:RWLK) In A Good Position To Invest In Growth?
Mar 07Here's Why We're Not Too Worried About ReWalk Robotics' (NASDAQ:RWLK) Cash Burn Situation
Oct 04ReWalk Robotics gets a new CFO
Sep 08ReWalK Q2 2022 Earnings Preview
Aug 08ReWalk Robotics receives Israeli court approval for $8M stock buyback
Jul 21ReWalk Robotics (NASDAQ:RWLK) Is In A Good Position To Deliver On Growth Plans
May 11ReWalk Robotics: Catalysts On The Horizon
Mar 09Here's Why We're Not Too Worried About ReWalk Robotics' (NASDAQ:RWLK) Cash Burn Situation
Jan 24ReWalk Robotics: Getting All Non-Cash Assets For Free
Nov 24We're Hopeful That ReWalk Robotics (NASDAQ:RWLK) Will Use Its Cash Wisely
Jun 22ReWalk Robotics: Plenty Of Runway To Re-Establish Growth
Jun 15We Think ReWalk Robotics (NASDAQ:RWLK) Can Afford To Drive Business Growth
Mar 08ReWalk Robotics: A Turbulent Journey In The Right Direction
Dec 22Shareholder Returns
| LFWD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -2.6% | -1.1% | 1.0% |
| 1Y | 5.8% | -0.9% | 20.8% |
Return vs Industry: LFWD exceeded the US Medical Equipment industry which returned -0.9% over the past year.
Return vs Market: LFWD underperformed the US Market which returned 20.8% over the past year.
Price Volatility
| LFWD volatility | |
|---|---|
| LFWD Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: LFWD's share price has been volatile over the past 3 months.
Volatility Over Time: LFWD's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 108 | Larry Jasinski | golifeward.com |
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.
ReWalk Robotics Ltd. Fundamentals Summary
| LFWD fundamental statistics | |
|---|---|
| Market cap | US$38.54m |
| Earnings (TTM) | -US$24.09m |
| Revenue (TTM) | US$17.91m |
2.2x
P/S Ratio-1.6x
P/E RatioIs LFWD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFWD income statement (TTM) | |
|---|---|
| Revenue | US$17.91m |
| Cost of Revenue | US$12.63m |
| Gross Profit | US$5.28m |
| Other Expenses | US$29.37m |
| Earnings | -US$24.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.80 |
| Gross Margin | 29.47% |
| Net Profit Margin | -134.52% |
| Debt/Equity Ratio | 0% |
How did LFWD perform over the long term?
See historical performance and comparison